Transplant Diagnostics Market size worth $ 1.15 Billion, Globally, by 2028 at 7.38% CAGR: Verified Market Research®

An increasing number of patients suffering from chronic diseases frequently leading to organ failure, the adoption of stem cell therapy and personalized medicine, is creating an upsurge in demand for transplant procedures.

JERSEY CITY, N.J., Nov. 16, 2021 /PRNewswire/ -- Verified Market Research recently published a report, "Transplant Diagnostics Market" By Technology (Molecular array, Non molecular array), By Products and Services (Instruments, Reagents and consumables, Software and services), By End-User (Hospitals and transplants centers, Commercial service providers), and By Geography. According to Verified Market Research, the Global Transplant Diagnostics Market size was valued at USD 653.97 Million in 2020 and is projected to reach USD 1.15 Billion by 2028, growing at a CAGR of 7.38% from 2021 to 2028.

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample/?rid=27617

Browse in-depth TOC on "Transplant Diagnostics Market"

202 - Pages
126 – Tables
37 – Figures

Global Transplant Diagnostics Market Overview

The rising number of stem-cell-based, soft tissues and solid transplantation, increasing geriatric population, rising occurrence of persistent diseases, augmentation in laboratory automation of diagnostic operations that are assisted by robots, and advancements in technology advancement in human leukocyte antigen typing are some of the crucial factors driving the growth of the global Transplant Diagnostics Market. Additionally, an increase in public and private investments to develop novel human leukocyte antigen (HLA) products for testing, the soaring number of HLA applications in diagnostics, improvement in healthcare infrastructure, especially in developing nations, consistent reduction average gene sequencing costs, and rising bases of installation of NGS and PCR instruments are steering the global Transplant Diagnostics Market growth.

According to the perspectives of SMEs of leading companies, the growing number of organ transplant procedures, technological advancements, rising incidence of chronic diseases, and increased R&D activities drive this market. However, organ shortage for transplant procedures, challenges in sequencing HLA, and lack of awareness hinder the market growth. Currently, the consumables segment generates maximum revenue. According to the SMEs, the increasing need for organ transplants creates a demand for transplant diagnostics. In addition, the majority of the transplant diagnostic manufacturers and distributors focus more on emerging markets due to the potential they hold.

Key Developments

• In August 2019, Care Dx (US) acquired Xyn Management (US) to simplify transplant quality tracking and waitlist management.
• In March 2019, Hologic established a learning and experience center in Zaventem (Belgium) to create awareness among customers, healthcare professionals, and employees across Europe, the Middle East, and Africa about the benefits of diagnostic products, including transplant diagnostic products.
• In February 2019, Care Dx (US) launched the Allosure for lung transplants.
• In January 2018, F. Hoffman-LA Roche Limited (Switzerland) launched the Cobas Plasma, Separation Card.

Key Players

The major players in the market are Abbott Laboratories, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-LA Roche, Ltd., Illumina, Inc., Immucor, Inc., Linkage Biosciences, Olerup SSP AB, Qiagen N.V., Sigma-Aldrich, Thermo Fisher Scientific, Inc.

Verified Market Research has segmented the Global Transplant Diagnostics Market On the basis of Technology, Products & Services, End-User, and Geography.

• Transplant Diagnostics Market, By Technology
• Molecular Array
• Non Molecular Array
• Transplant Diagnostics Market, By Products and Services
• Instruments
• Reagents And Consumables
• Software And Services
• Transplant Diagnostics Market, By End-User
• Hospitals and transplants centers
• Commercial service providers
• Research laboratories and academic institutes
• Others
• Transplant Diagnostics Market by Geography
• North America
• U.S
• Canada
• Mexico
• Europe
• Germany
• France
• U.K
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Rest of Asia Pacific
• ROW
• Middle East & Africa
• Latin America

Browse Related Reports:

Ophthalmic Viscoelastic Devices Market By Product Type (Cohesive Ophthalmic Viscoelastic, Dispersive Ophthalmic Viscoelastic), By Application (Cataract, Glaucoma, Corneal Transplant), By Geography, Forecast, 2021-2028

Microsurgery Market By Procedure (Transplantation, Free Tissue Transfer, Replantation, Treatment of Infertility), By Application (General Surgery, Orthopedic Surgery, Oncology, Gynecological Surgery), By End User (Hospitals And Clinics, Research Institutes, Ambulatory Surgical Centers), By Geography, Forecast, 2021-2028

HLA Typing For Transplant Market By Application (Research Applications, Diagnostic Applications), By Products And Services (Reagents and Consumables, Software and Services), By End User (Commercial Service Providers, Hospitals and Transplant Centers), By Technology (Non Molecular Assays, Molecular Assays), By Geography, Forecast, 2021-2028

Ophthalmic Sutures Market By Type (Natural and Synthetic), By End User (Hospitals, Ambulatory Surgical Centers and Others), By Absorption Capacity (Absorbable & Non-Absorbable), By Application (Corneal Transplantation Surgery, Cataract Surgery, Vitrectomy Surgery & Others), By Geography, Forecast, 2021-2028

Top 10 Point-Of-Care Molecular Diagnostics Companies supplying improved testing methods

Visualize Transplant Diagnostics Market using Verified Market Intelligence:-:

Verified Market Intelligence is our BI Enabled Platform for narrative storytelling of this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue impacting decisions for a brilliant future.

VMI provides a holistic overview and global competitive landscape with respect to Region, Country, and Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.

About Us

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SME's offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

We study 14+ categories from Semiconductor & Electronics, Chemicals, Advanced Materials, Aerospace & Defense, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & construction, Agriculture industry and Medical Devices from over 100 countries.

Contact Us

Mr. Edwyne Fernandes
Verified Market Research®
US: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US Toll Free: +1 (800)-782-1768
Email: sales@verifiedmarketresearch.com
Web: https://www.verifiedmarketresearch.com/
Follow Us: LinkedIn | Twitter

Logo: https://mma.prnewswire.com/media/1315349/Verified_Market_Research_Logo.jpg